The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…
Read More »Elevai
ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…
Read More »Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…
Read More »Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…
Read More »Last Updated: Dmark Multisales Corp. is a Prominent Marketing and Distribution Company Based in the Philippines With Over 20 Years…
Read More »ELEVAI Secured its Non-Repayable Grant From the Mitacs Accelerate Grants Program (Mitacs) and Will Be Conducting its Research Partnership With…
Read More »ELEVAI Labs is Set to Launch its New Groundbreaking Approach to Pre- and Post-Procedure Skincare ELEVAI Labs, a science-based, data-driven…
Read More »Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…
Read More »